Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Gender differences in obstructive sleep apnoea, insomnia and restless legs syndrome in adults - What do we know? A clinical update.

Theorell-Haglöw J, Miller CB, Bartlett DJ, Yee BJ, Openshaw HD, Grunstein RR.

Sleep Med Rev. 2018 Apr;38:28-38. doi: 10.1016/j.smrv.2017.03.003. Epub 2017 Mar 27. Review.

PMID:
28495359
2.

High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Steinmiller KC, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stuve O, Arnold DL, Wener MH, Georges GE, Wundes A, Kraft GH, Bowen JD.

Neurology. 2017 Feb 28;88(9):842-852. doi: 10.1212/WNL.0000000000003660. Epub 2017 Feb 1.

3.

Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivation.

Ramakrishna C, Ferraioli A, Calle A, Nguyen TK, Openshaw H, Lundberg PS, Lomonte P, Cantin EM.

PLoS Pathog. 2015 Mar 11;11(3):e1004730. doi: 10.1371/journal.ppat.1004730. eCollection 2015 Mar.

4.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

5.

The case for immunomodulatory approaches in treating HSV encephalitis.

Ramakrishna C, Openshaw H, Cantin EM.

Future Virol. 2013 Mar 1;8(3):259-272.

6.

Brain imaging findings in symptomatic patients after allogeneic haematopoietic stem cell transplantation: correlation with clinical outcome.

Chen BT, Ortiz AO, Dagis A, Torricelli C, Parker P, Openshaw H.

Eur Radiol. 2012 Oct;22(10):2273-81. doi: 10.1007/s00330-012-2490-6. Epub 2012 May 23.

PMID:
22618523
7.

Predicting acute and persistent neuropathy associated with oxaliplatin.

Alejandro LM, Behrendt CE, Chen K, Openshaw H, Shibata S.

Am J Clin Oncol. 2013 Aug;36(4):331-7. doi: 10.1097/COC.0b013e318246b50d.

8.

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results.

Bowen JD, Kraft GH, Wundes A, Guan Q, Maravilla KR, Gooley TA, McSweeney PA, Pavletic SZ, Openshaw H, Storb R, Wener M, McLaughlin BA, Henstorf GR, Nash RA.

Bone Marrow Transplant. 2012 Jul;47(7):946-51. doi: 10.1038/bmt.2011.208. Epub 2011 Nov 7.

9.

The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.

Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM.

J Virol. 2008 Jul;82(14):7078-88. doi: 10.1128/JVI.00619-08. Epub 2008 May 14.

10.

Lumbar puncture and subdural hygroma and hematomas in hematopoietic cell transplant patients.

Openshaw H, Ressler JA, Snyder DS.

Bone Marrow Transplant. 2008 May;41(9):791-5. doi: 10.1038/sj.bmt.1705971. Epub 2008 Feb 4.

PMID:
18246118
11.

Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent.

Lundberg P, Openshaw H, Wang M, Yang HJ, Cantin E.

Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4162-70.

PMID:
17724202
12.

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Atkins HL, Azzarelli B, Kolar OJ, Brück W.

Brain. 2007 May;130(Pt 5):1254-62. Epub 2007 Feb 9.

PMID:
17293360
13.

Multiple sclerosis conference synopsis and discussion: cellular therapy for treatment of autoimmune diseases (October 2005).

Openshaw H, Atkins HL, Chen JT, de Bittencourt PR, Griffith LM, Kerr DA, Khoury SA, Muraro PA, Nash RA, Saccardi R.

Mult Scler. 2006 Dec;12(6):824-5.

PMID:
17263013
14.

Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.

Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Löwenberg B, te Boekhorst PA, Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA, Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A, Steck AJ, Andolina M, Capobianco M, Martin JL, Lugaresi A, Meucci G, Sáez RA, Clark RE, Fernandez MN, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H, Mancardi GL; Autoimmune Diseases Working Party of EBMT.

Mult Scler. 2006 Dec;12(6):814-23.

PMID:
17263012
15.

Unilateral mydriasis from ipratropium in transplant patients.

Openshaw H.

Neurology. 2006 Sep 12;67(5):914. No abstract available.

PMID:
16966571
16.

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.

Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA; Workshop participants.

Biol Blood Marrow Transplant. 2005 Nov;11(11):862-70. No abstract available.

17.

Corticosteroids in herpes simplex virus encephalitis.

Openshaw H, Cantin EM.

J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1469. No abstract available.

18.

The effect of height on paclitaxel nerve damage.

Openshaw H, Beamon K, Longmate J, Synold T, Slatkin NE, Somlo G.

J Neurooncol. 2005 Sep;74(2):207-10.

PMID:
16193394
19.

Kernohan notch lesion after spinal tap.

Openshaw H.

Neurology. 2005 May 10;64(9):1631. No abstract available.

PMID:
15883331
20.

Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.

Openshaw H, Beamon K, Synold TW, Longmate J, Slatkin NE, Doroshow JH, Forman S, Margolin K, Morgan R, Shibata S, Somlo G.

Clin Cancer Res. 2004 Jan 15;10(2):461-7.

21.
22.

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH.

Blood. 2003 Oct 1;102(7):2364-72. Epub 2003 May 22.

23.
24.

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

Fassas A, Passweg JR, Anagnostopoulos A, Kazis A, Kozak T, Havrdova E, Carreras E, Graus F, Kashyap A, Openshaw H, Schipperus M, Deconinck E, Mancardi G, Marmont A, Hansz J, Rabusin M, Zuazu Nagore FJ, Besalduch J, Dentamaro T, Fouillard L, Hertenstein B, La Nasa G, Musso M, Papineschi F, Rowe JM, Saccardi R, Steck A, Kappos L, Gratwohl A, Tyndall A, Samijn J; Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation).

J Neurol. 2002 Aug;249(8):1088-97. Erratum in: J Neurol. 2002 Nov;249(11):1619.. Samign, J [corrected to Samijn, J]. J Neurol. 2002 Oct;249(10):1482..

PMID:
12195460
25.

High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review.

Openshaw H, Nash RA, McSweeney PA.

Biol Blood Marrow Transplant. 2002;8(5):233-48. Review.

26.

Eye movement abnormality associated with cyclosporin.

Openshaw H.

J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):809. No abstract available.

27.

Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice.

Han X, Lundberg P, Tanamachi B, Openshaw H, Longmate J, Cantin E.

J Virol. 2001 Mar;75(6):3048-52. Erratum in: J Virol 2001 Aug;75(16):7789.

28.

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring.

Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, Forman S.

Biol Blood Marrow Transplant. 2000;6(5A):563-75.

PMID:
11071262
29.

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor.

Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP, Kashyap A, McSweeney P, Forman S.

Neurology. 2000 Jun 13;54(11):2147-50.

PMID:
10851379
31.

Role for gamma interferon in control of herpes simplex virus type 1 reactivation.

Cantin E, Tanamachi B, Openshaw H.

J Virol. 1999 Apr;73(4):3418-23.

32.
33.

Myositis associated with graft-versus-host disease.

Parker PM, Openshaw H, Forman SJ.

Curr Opin Rheumatol. 1997 Nov;9(6):513-9. Review.

PMID:
9375280
34.

Peripheral neuropathy after bone marrow transplantation.

Openshaw H.

Biol Blood Marrow Transplant. 1997 Oct;3(4):202-9. Review.

PMID:
9360782
35.

Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir.

Openshaw H, Slatkin NE, Smith E.

Bone Marrow Transplant. 1997 Mar;19(5):503-5.

36.

Genetic and functional complementation of the HSV1 UL27 gene and gB glycoprotein by simian alpha-herpesvirus homologs.

Eberle R, Tanamachi B, Black D, Blewett EL, Ali M, Openshaw H, Cantin EM.

Arch Virol. 1997;142(4):721-36.

PMID:
9170500
37.

Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.

Openshaw H, Slatkin NE, Stein AS, Hinton DR, Forman SJ.

Cancer. 1996 Nov 1;78(9):1899-905.

PMID:
8909309
38.

Polymyositis as a manifestation of chronic graft-versus-host disease.

Parker P, Chao NJ, Ben-Ezra J, Slatkin N, Openshaw H, Niland JC, Linker CA, Greffe BS, Kashyap A, Molina A, Nademanee A, O'Donnell MR, Planas I, Sheibani K, Smith EP, Snyder DS, Spielberger R, Stein AS, Stepan DE, Blume KG, Forman SJ.

Medicine (Baltimore). 1996 Sep;75(5):279-85. Review.

40.
41.

Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia.

Openshaw H, McNeill JI, Lin XH, Niland J, Cantin EM.

J Med Virol. 1995 May;46(1):75-80.

PMID:
7623011
42.

Immune-mediated myelopathy after allogeneic marrow transplantation.

Openshaw H, Slatkin NE, Parker PM, Forman SJ.

Bone Marrow Transplant. 1995 Apr;15(4):633-6.

PMID:
7655392
43.

Antiviral effects of herpes simplex virus specific anti-sense nucleic acids.

Cantin EM, Podsakoff G, Willey DE, Openshaw H.

Adv Exp Med Biol. 1992;312:139-49. Review.

PMID:
1325101
44.

Exacerbation of inflammatory demyelinating polyneuropathy after bone marrow transplantation.

Openshaw H, Hinton DR, Slatkin NE, Bierman PJ, Hoffman FM, Snyder DS.

Bone Marrow Transplant. 1991 May;7(5):411-4.

PMID:
1906357
45.

Early loss of astrocytes in herpes simplex virus-induced central nervous system demyelination.

Itoyama Y, Sekizawa T, Openshaw H, Kogure K, Goto I.

Ann Neurol. 1991 Mar;29(3):285-92.

PMID:
2042945
46.

Acute retinitis 2 years after recovery from herpes simplex encephalitis.

Sekizawa T, Hara S, Kiyosawa M, Openshaw H, Kogure K.

Neurology. 1991 Mar;41(3):456. No abstract available.

PMID:
2006022
47.

Application of polymerase chain reaction assays to studies of herpes simplex virus latency.

Cantin EM, Lange W, Openshaw H.

Intervirology. 1991;32(2):93-100.

PMID:
1851147
48.

Ocular acyclovir delivery by collagen discs: a mouse model to screen anti-viral agents.

Willey DE, Williams I, Faucett C, Openshaw H.

Curr Eye Res. 1991;10 Suppl:167-9.

PMID:
1650665
49.

Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays.

Cantin EM, Chen J, McNeill J, Willey DE, Openshaw H.

Curr Eye Res. 1991;10 Suppl:15-21.

PMID:
1650662
50.

Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection.

Willey DE, Cantin EM, Hill LR, Moss B, Notkins AL, Openshaw H.

J Infect Dis. 1988 Dec;158(6):1382-6. No abstract available.

PMID:
2848904

Supplemental Content

Loading ...
Support Center